Taysha Gene Therapies Inc R&D Day 1 Transcript
Good morning, and welcome to day 1 of Taysha Gene Therapies First R&D Day. (Operator Instructions) Today, the company will present new data and updates for many of its pipeline candidates. Joining the call today is R.A. Session II, Taysha's President, Founder and Chief Executive Officer; Dr. Suyash Prasad, Chief Medical Officer and Head of R&D; and Dr. Steve Gray, Chief Scientific Adviser and Associate Professor in the Department of Pediatrics at UT Southwestern.
Before we begin, please note that this presentation will include forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Please see Slide 2 of the accompanying presentation and Taysha's SEC filings for important risk factors that could cause the company's actual performance and results to differ materially from those expressed or implied in these forward-looking statements. Taysha undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this conference call
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
